List View

By /

Clear

Displaying 1,401 - 1,425 of 2,995

Toxicities in Immunotherapy

Toxicities in Immunotherapy

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer

Immunotherapy for Triple Negative Breast Cancer

Immunotherapy for Triple Negative Breast Cancer

Immunotherapy for Triple Negative Breast Cancer

Immunotherapy for Triple Negative Breast Cancer

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

Novel Platforms for Lung Cancer Screening Using Liquid Biopsy

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC